Mortality rate after coronary revascularization in heart failure patients with coronary artery disease.
Vanessa NaderAnthony MattaRyeonshi KangAntoine DeneyRania AzarCharlotte Rouzaud-LabordeOxana KunduzovaRomain ItierPauline FournierMichel GalinierDidier CarriéJerome RoncalliPublished in: ESC heart failure (2023)
Findings from the present study showed comparable all-cause mortality rates between groups. Coronary revascularization does not modify short-term survival outcomes in HF patients compared with optimal medical therapy alone outside the setting of acute coronary syndrome.
Keyphrases
- acute coronary syndrome
- heart failure
- percutaneous coronary intervention
- coronary artery disease
- end stage renal disease
- coronary artery
- ejection fraction
- coronary artery bypass grafting
- newly diagnosed
- chronic kidney disease
- aortic stenosis
- healthcare
- cardiovascular events
- acute heart failure
- left ventricular
- stem cells
- atrial fibrillation
- mesenchymal stem cells
- patient reported outcomes
- aortic valve